Yongsheng Liu Selected Research

ribonuclease R (RNase R)

10/2022

Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongsheng Liu Research Topics

Disease

22	Neoplasms (Cancer) 10/2022 - 08/2002
9	Infections 01/2022 - 03/2013
5	Neoplasm Metastasis (Metastasis) 10/2022 - 09/2012
5	Aneurysm (Aneurysms) 01/2021 - 09/2017
4	Inflammation (Inflammations) 01/2022 - 01/2015
3	Hypoxia (Hypoxemia) 01/2022 - 01/2019
3	COVID-19 01/2021 - 01/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019 - 04/2009
2	Carcinogenesis 10/2022 - 01/2015
2	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 07/2021
2	Myocardial Infarction 03/2022 - 01/2019
2	Infarction (Infarctions) 03/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2018
2	Insulin Resistance 12/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 07/2019
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 03/2020
2	Ischemia 01/2021 - 08/2018
2	Intracranial Aneurysm (Cerebral Aneurysm) 09/2020 - 11/2017
2	Dehydration (Water Stress) 03/2012 - 11/2008
1	Ovarian Neoplasms (Ovarian Cancer) 05/2022
1	Dysentery 04/2022
1	Mastitis 04/2022
1	Colonic Neoplasms (Colon Cancer) 04/2022
1	Colitis-Associated Neoplasms 04/2022
1	Fibrosis (Cirrhosis) 03/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022
1	Vesicular Stomatitis 01/2022
1	Right Ventricular Hypertrophy 12/2021
1	Pulmonary Arterial Hypertension 12/2021
1	Vascular Remodeling 12/2021
1	Bites and Stings (Sting) 12/2021
1	AIDS-Related Complex (ARC) 07/2021
1	Arthrogryposis renal dysfunction cholestasis syndrome 07/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2010
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
4	Tumor Biomarkers (Tumor Markers)IBA 11/2016 - 08/2013
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2018
3	Biological ProductsIBA 02/2016 - 08/2002
2	Radioisotopes (Radionuclides)IBA 05/2022 - 01/2021
2	Designed Ankyrin Repeat ProteinsIBA 05/2022 - 07/2021
2	Epithelial Cell Adhesion MoleculeIBA 05/2022 - 07/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 06/2018
2	human ERBB2 proteinIBA 01/2022 - 09/2020
2	VaccinesIBA 01/2022 - 04/2018
2	CoumarinsIBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2019
2	InterferonsIBA 12/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2021
2	CytokinesIBA 01/2021 - 07/2016
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2019
2	Angiotensin IIIBA 01/2021 - 03/2020
2	Peptide Hydrolases (Proteases)FDA Link 09/2020 - 08/2002
2	oxidized low density lipoproteinIBA 09/2020 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019 - 02/2016
2	EnzymesIBA 01/2019 - 08/2002
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2018
2	Lanthanoid Series Elements (Lanthanides)IBA 11/2016 - 08/2013
2	AvidinIBA 10/2014 - 09/2012
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2013 - 08/2002
2	Urokinase Plasminogen Activator ReceptorsIBA 07/2013 - 09/2012
2	Interleukin-18 (Interleukin 18)IBA 06/2010 - 04/2009
1	ribonuclease R (RNase R)IBA 10/2022
1	Circular RNAIBA 10/2022
1	Immunoconjugates (Immunoconjugate)IBA 05/2022
1	ExotoxinsIBA 05/2022
1	Chloride Channels (Chloride Channel)IBA 04/2022
1	PoisonsIBA 04/2022
1	InterleukinsIBA 03/2022
1	CollagenIBA 03/2022
1	Mitogen-Activated Protein Kinase 3IBA 03/2022
1	Mitogen-Activated Protein KinasesIBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	peiminineIBA 03/2022
1	bacteriophage T7 RNA polymerase (T7 RNA polymerase)IBA 01/2022
1	pyrimidineIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Semaphorin-3AIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	CalciumIBA 12/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2021
1	Uncoupling Protein 2IBA 12/2021
1	Mitochondrial Uncoupling ProteinsIBA 12/2021
1	Sirtuin 3IBA 12/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2021
1	CarbonatesIBA 07/2021
1	Indium-111IBA 07/2021
1	sym-trinitrobenzeneIBA 04/2021
1	Sulfonic AcidsIBA 04/2021

Therapy/Procedure

10	Therapeutics 05/2022 - 10/2009
5	Stents 09/2020 - 12/2012
2	Radiotherapy 07/2020 - 01/2020
1	Ligation 03/2022
1	Transplantation 12/2021
1	Immunotherapy 12/2021